Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
CA 2375602 A1 · Owner: Choppin, Jeannine · Inventors: Guillet, Jean-Gerard; Connan, Francine; Choppin, Jeannine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of polyepitopic fragments of a determined protein for the production of medicaments designed to prevent or treat pathologies in which said protein is recognized by the cellular immune system and said polyepitopic fragments are chosen from the HIV Nef protein. The invention also relates to polyepitopic proteinic fragments of the HIV Nef protein a method for the production and use thereof especially in the field of vaccination.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 31, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 31, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 31, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.